India Ranks Second in Hepatitis B and C Cases Worldwide

The World Health Organisation’s (WHO) 2024 Global Hepatitis Report reveals that India is second only to China in the number of Hepatitis B and C infections, with 3.5 crore cases. Hepatitis, characterized by liver inflammation, poses significant health risks and can be fatal. The report highlights that 254 million people are affected by Hepatitis B and 50 million by Hepatitis C globally.

Understanding Hepatitis

Hepatitis comprises five main strains: A, B, C, D, and E, each differing in transmission methods, severity, and geographical prevalence. Despite these differences, all strains can lead to liver disease.

Chronic Infections Among Specific Age Groups

The report emphasizes that individuals aged 30–54 bear half the burden of chronic Hepatitis B and C infections. This demographic insight underscores the urgency of targeted interventions and healthcare strategies to address this public health challenge.

WHO’s Commitment to Combatting Hepatitis

WHO pledges its support to countries in deploying effective tools at accessible prices to combat Hepatitis and reduce its impact on global health. This commitment aims to save lives and reverse the upward trend of Hepatitis infections worldwide.